Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions

L. Wideroff, M. Schiffman, P. Haderer, A. Armstrong, C. E. Greer, M. M. Manos, Robert D. Burk, D. R. Scott, M. E. Sherman, J. T. Schiller, R. N. Hoover, R. E. Tarone, R. Kirnbauer

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Serum IgG antibodies to human papillomavirus (HPV) types 16, 18, 31, and 45 virus-like particles were measured in a nested case-control study of cervical squamous intraepithelial lesions. HPV-16 seroreactivity was strongly associated with HPV-16 DNA detection (odds ratio, 9.0; 95% confidence interval, 4.4-19.4), and similar type specificity was observed for HPV-31 and -45. In contrast, seroreactivity to any type was associated with elevated seroreactivity to all others. Among cases and controls, HPV-16 showed the highest seroprevalence, with 23.8% of 80 cases and 10.5% of 258 controls seroreactive to HPV-16 alone, and another 27.5% and 5.4%, respectively, seroreactive to HPV-16 plus other types. Overall, 24 (30.0%) cases and 17 (6.6%) controls were seroreactive to multiple types. These data suggest that seroreactivity to a given type reflects mainly type-specific HPV infection as measured by DNA detection and may also signal past exposure to other types that are now only serologically detected.

Original languageEnglish (US)
Pages (from-to)1424-1428
Number of pages5
JournalJournal of Infectious Diseases
Volume180
Issue number5
DOIs
StatePublished - 1999

Fingerprint

Human papillomavirus 18
Human papillomavirus 16
Virion
Case-Control Studies
Human papillomavirus 31
Papillomavirus Infections
DNA
Seroepidemiologic Studies
Squamous Intraepithelial Lesions of the Cervix
Immunoglobulin G
Odds Ratio
Confidence Intervals
Antibodies
Serum

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions. / Wideroff, L.; Schiffman, M.; Haderer, P.; Armstrong, A.; Greer, C. E.; Manos, M. M.; Burk, Robert D.; Scott, D. R.; Sherman, M. E.; Schiller, J. T.; Hoover, R. N.; Tarone, R. E.; Kirnbauer, R.

In: Journal of Infectious Diseases, Vol. 180, No. 5, 1999, p. 1424-1428.

Research output: Contribution to journalArticle

Wideroff, L, Schiffman, M, Haderer, P, Armstrong, A, Greer, CE, Manos, MM, Burk, RD, Scott, DR, Sherman, ME, Schiller, JT, Hoover, RN, Tarone, RE & Kirnbauer, R 1999, 'Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions', Journal of Infectious Diseases, vol. 180, no. 5, pp. 1424-1428. https://doi.org/10.1086/315055
Wideroff, L. ; Schiffman, M. ; Haderer, P. ; Armstrong, A. ; Greer, C. E. ; Manos, M. M. ; Burk, Robert D. ; Scott, D. R. ; Sherman, M. E. ; Schiller, J. T. ; Hoover, R. N. ; Tarone, R. E. ; Kirnbauer, R. / Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions. In: Journal of Infectious Diseases. 1999 ; Vol. 180, No. 5. pp. 1424-1428.
@article{c8f73282a7bc4d3ebff8b639431495a8,
title = "Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions",
abstract = "Serum IgG antibodies to human papillomavirus (HPV) types 16, 18, 31, and 45 virus-like particles were measured in a nested case-control study of cervical squamous intraepithelial lesions. HPV-16 seroreactivity was strongly associated with HPV-16 DNA detection (odds ratio, 9.0; 95{\%} confidence interval, 4.4-19.4), and similar type specificity was observed for HPV-31 and -45. In contrast, seroreactivity to any type was associated with elevated seroreactivity to all others. Among cases and controls, HPV-16 showed the highest seroprevalence, with 23.8{\%} of 80 cases and 10.5{\%} of 258 controls seroreactive to HPV-16 alone, and another 27.5{\%} and 5.4{\%}, respectively, seroreactive to HPV-16 plus other types. Overall, 24 (30.0{\%}) cases and 17 (6.6{\%}) controls were seroreactive to multiple types. These data suggest that seroreactivity to a given type reflects mainly type-specific HPV infection as measured by DNA detection and may also signal past exposure to other types that are now only serologically detected.",
author = "L. Wideroff and M. Schiffman and P. Haderer and A. Armstrong and Greer, {C. E.} and Manos, {M. M.} and Burk, {Robert D.} and Scott, {D. R.} and Sherman, {M. E.} and Schiller, {J. T.} and Hoover, {R. N.} and Tarone, {R. E.} and R. Kirnbauer",
year = "1999",
doi = "10.1086/315055",
language = "English (US)",
volume = "180",
pages = "1424--1428",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus- like particles in a case-control study of cervical squamous intraepithelial lesions

AU - Wideroff, L.

AU - Schiffman, M.

AU - Haderer, P.

AU - Armstrong, A.

AU - Greer, C. E.

AU - Manos, M. M.

AU - Burk, Robert D.

AU - Scott, D. R.

AU - Sherman, M. E.

AU - Schiller, J. T.

AU - Hoover, R. N.

AU - Tarone, R. E.

AU - Kirnbauer, R.

PY - 1999

Y1 - 1999

N2 - Serum IgG antibodies to human papillomavirus (HPV) types 16, 18, 31, and 45 virus-like particles were measured in a nested case-control study of cervical squamous intraepithelial lesions. HPV-16 seroreactivity was strongly associated with HPV-16 DNA detection (odds ratio, 9.0; 95% confidence interval, 4.4-19.4), and similar type specificity was observed for HPV-31 and -45. In contrast, seroreactivity to any type was associated with elevated seroreactivity to all others. Among cases and controls, HPV-16 showed the highest seroprevalence, with 23.8% of 80 cases and 10.5% of 258 controls seroreactive to HPV-16 alone, and another 27.5% and 5.4%, respectively, seroreactive to HPV-16 plus other types. Overall, 24 (30.0%) cases and 17 (6.6%) controls were seroreactive to multiple types. These data suggest that seroreactivity to a given type reflects mainly type-specific HPV infection as measured by DNA detection and may also signal past exposure to other types that are now only serologically detected.

AB - Serum IgG antibodies to human papillomavirus (HPV) types 16, 18, 31, and 45 virus-like particles were measured in a nested case-control study of cervical squamous intraepithelial lesions. HPV-16 seroreactivity was strongly associated with HPV-16 DNA detection (odds ratio, 9.0; 95% confidence interval, 4.4-19.4), and similar type specificity was observed for HPV-31 and -45. In contrast, seroreactivity to any type was associated with elevated seroreactivity to all others. Among cases and controls, HPV-16 showed the highest seroprevalence, with 23.8% of 80 cases and 10.5% of 258 controls seroreactive to HPV-16 alone, and another 27.5% and 5.4%, respectively, seroreactive to HPV-16 plus other types. Overall, 24 (30.0%) cases and 17 (6.6%) controls were seroreactive to multiple types. These data suggest that seroreactivity to a given type reflects mainly type-specific HPV infection as measured by DNA detection and may also signal past exposure to other types that are now only serologically detected.

UR - http://www.scopus.com/inward/record.url?scp=0032703640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032703640&partnerID=8YFLogxK

U2 - 10.1086/315055

DO - 10.1086/315055

M3 - Article

C2 - 10515799

AN - SCOPUS:0032703640

VL - 180

SP - 1424

EP - 1428

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -